The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antihelminthics-Global Market Insights and Sales Trends 2024
Synopsis
Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host.
The global Antihelminthics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Antihelminthics in various end use industries. The expanding demands from the Schistosomiasis, Fasciolasis, Filariasis and Angiostrongylosis, are propelling Antihelminthics market. Benzimidazoles, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Abamectin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antihelminthics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antihelminthics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antihelminthics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antihelminthics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antihelminthics covered in this report include Abbott, Novartis, ZEISS International, Johnson & Johnson, Sanofi, Merck & Co., GlaxoSmithKline, Astellas Pharma and Bayer, etc.
The global Antihelminthics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Novartis
ZEISS International
Johnson & Johnson
Sanofi
Merck & Co.
GlaxoSmithKline
Astellas Pharma
Bayer
Mentis Pharma
Pfizer
Sanofi
ALLERGAN
AstraZeneca
Global Antihelminthics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antihelminthics market, Segment by Type:
Benzimidazoles
Abamectin
Salicylanilides
Praziquantel
Other
Global Antihelminthics market, by Application
Schistosomiasis
Fasciolasis
Filariasis
Angiostrongylosis
Ascariasis
Giardiasis
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antihelminthics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antihelminthics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host.
The global Antihelminthics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Antihelminthics in various end use industries. The expanding demands from the Schistosomiasis, Fasciolasis, Filariasis and Angiostrongylosis, are propelling Antihelminthics market. Benzimidazoles, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Abamectin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antihelminthics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antihelminthics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antihelminthics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antihelminthics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antihelminthics covered in this report include Abbott, Novartis, ZEISS International, Johnson & Johnson, Sanofi, Merck & Co., GlaxoSmithKline, Astellas Pharma and Bayer, etc.
The global Antihelminthics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Novartis
ZEISS International
Johnson & Johnson
Sanofi
Merck & Co.
GlaxoSmithKline
Astellas Pharma
Bayer
Mentis Pharma
Pfizer
Sanofi
ALLERGAN
AstraZeneca
Global Antihelminthics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antihelminthics market, Segment by Type:
Benzimidazoles
Abamectin
Salicylanilides
Praziquantel
Other
Global Antihelminthics market, by Application
Schistosomiasis
Fasciolasis
Filariasis
Angiostrongylosis
Ascariasis
Giardiasis
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antihelminthics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antihelminthics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Antihelminthics Market Overview
1.1 Antihelminthics Product Overview
1.2 Antihelminthics Market Segment by Type
1.2.1 Benzimidazoles
1.2.2 Abamectin
1.2.3 Salicylanilides
1.2.4 Praziquantel
1.2.5 Other
1.3 Global Antihelminthics Market Size by Type
1.3.1 Global Antihelminthics Market Size Overview by Type (2018-2029)
1.3.2 Global Antihelminthics Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antihelminthics Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antihelminthics Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antihelminthics Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antihelminthics Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antihelminthics Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antihelminthics Sales Breakdown by Type (2018-2023)
2 Global Antihelminthics Market Competition by Company
2.1 Global Top Players by Antihelminthics Sales (2018-2023)
2.2 Global Top Players by Antihelminthics Revenue (2018-2023)
2.3 Global Top Players by Antihelminthics Price (2018-2023)
2.4 Global Top Manufacturers Antihelminthics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antihelminthics Market Competitive Situation and Trends
2.5.1 Antihelminthics Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antihelminthics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antihelminthics as of 2022)
2.7 Date of Key Manufacturers Enter into Antihelminthics Market
2.8 Key Manufacturers Antihelminthics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antihelminthics Status and Outlook by Region
3.1 Global Antihelminthics Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antihelminthics Historic Market Size by Region
3.2.1 Global Antihelminthics Sales in Volume by Region (2018-2023)
3.2.2 Global Antihelminthics Sales in Value by Region (2018-2023)
3.2.3 Global Antihelminthics Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antihelminthics Forecasted Market Size by Region
3.3.1 Global Antihelminthics Sales in Volume by Region (2024-2029)
3.3.2 Global Antihelminthics Sales in Value by Region (2024-2029)
3.3.3 Global Antihelminthics Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antihelminthics by Application
4.1 Antihelminthics Market Segment by Application
4.1.1 Schistosomiasis
4.1.2 Fasciolasis
4.1.3 Filariasis
4.1.4 Angiostrongylosis
4.1.5 Ascariasis
4.1.6 Giardiasis
4.1.7 Other
4.2 Global Antihelminthics Market Size by Application
4.2.1 Global Antihelminthics Market Size Overview by Application (2018-2029)
4.2.2 Global Antihelminthics Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antihelminthics Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antihelminthics Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antihelminthics Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antihelminthics Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antihelminthics Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antihelminthics Sales Breakdown by Application (2018-2023)
5 North America Antihelminthics by Country
5.1 North America Antihelminthics Historic Market Size by Country
5.1.1 North America Antihelminthics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antihelminthics Sales in Volume by Country (2018-2023)
5.1.3 North America Antihelminthics Sales in Value by Country (2018-2023)
5.2 North America Antihelminthics Forecasted Market Size by Country
5.2.1 North America Antihelminthics Sales in Volume by Country (2024-2029)
5.2.2 North America Antihelminthics Sales in Value by Country (2024-2029)
6 Europe Antihelminthics by Country
6.1 Europe Antihelminthics Historic Market Size by Country
6.1.1 Europe Antihelminthics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antihelminthics Sales in Volume by Country (2018-2023)
6.1.3 Europe Antihelminthics Sales in Value by Country (2018-2023)
6.2 Europe Antihelminthics Forecasted Market Size by Country
6.2.1 Europe Antihelminthics Sales in Volume by Country (2024-2029)
6.2.2 Europe Antihelminthics Sales in Value by Country (2024-2029)
7 Asia-Pacific Antihelminthics by Region
7.1 Asia-Pacific Antihelminthics Historic Market Size by Region
7.1.1 Asia-Pacific Antihelminthics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antihelminthics Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antihelminthics Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antihelminthics Forecasted Market Size by Region
7.2.1 Asia-Pacific Antihelminthics Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antihelminthics Sales in Value by Region (2024-2029)
8 Latin America Antihelminthics by Country
8.1 Latin America Antihelminthics Historic Market Size by Country
8.1.1 Latin America Antihelminthics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antihelminthics Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antihelminthics Sales in Value by Country (2018-2023)
8.2 Latin America Antihelminthics Forecasted Market Size by Country
8.2.1 Latin America Antihelminthics Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antihelminthics Sales in Value by Country (2024-2029)
9 Middle East and Africa Antihelminthics by Country
9.1 Middle East and Africa Antihelminthics Historic Market Size by Country
9.1.1 Middle East and Africa Antihelminthics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antihelminthics Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antihelminthics Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antihelminthics Forecasted Market Size by Country
9.2.1 Middle East and Africa Antihelminthics Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antihelminthics Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott
10.1.1 Abbott Company Information
10.1.2 Abbott Introduction and Business Overview
10.1.3 Abbott Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Antihelminthics Products Offered
10.1.5 Abbott Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis Antihelminthics Products Offered
10.2.5 Novartis Recent Development
10.3 ZEISS International
10.3.1 ZEISS International Company Information
10.3.2 ZEISS International Introduction and Business Overview
10.3.3 ZEISS International Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 ZEISS International Antihelminthics Products Offered
10.3.5 ZEISS International Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Johnson & Johnson Antihelminthics Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sanofi Antihelminthics Products Offered
10.5.5 Sanofi Recent Development
10.6 Merck & Co.
10.6.1 Merck & Co. Company Information
10.6.2 Merck & Co. Introduction and Business Overview
10.6.3 Merck & Co. Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Merck & Co. Antihelminthics Products Offered
10.6.5 Merck & Co. Recent Development
10.7 GlaxoSmithKline
10.7.1 GlaxoSmithKline Company Information
10.7.2 GlaxoSmithKline Introduction and Business Overview
10.7.3 GlaxoSmithKline Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
10.7.4 GlaxoSmithKline Antihelminthics Products Offered
10.7.5 GlaxoSmithKline Recent Development
10.8 Astellas Pharma
10.8.1 Astellas Pharma Company Information
10.8.2 Astellas Pharma Introduction and Business Overview
10.8.3 Astellas Pharma Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Astellas Pharma Antihelminthics Products Offered
10.8.5 Astellas Pharma Recent Development
10.9 Bayer
10.9.1 Bayer Company Information
10.9.2 Bayer Introduction and Business Overview
10.9.3 Bayer Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Bayer Antihelminthics Products Offered
10.9.5 Bayer Recent Development
10.10 Mentis Pharma
10.10.1 Mentis Pharma Company Information
10.10.2 Mentis Pharma Introduction and Business Overview
10.10.3 Mentis Pharma Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Mentis Pharma Antihelminthics Products Offered
10.10.5 Mentis Pharma Recent Development
10.11 Pfizer
10.11.1 Pfizer Company Information
10.11.2 Pfizer Introduction and Business Overview
10.11.3 Pfizer Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Pfizer Antihelminthics Products Offered
10.11.5 Pfizer Recent Development
10.12 Sanofi
10.12.1 Sanofi Company Information
10.12.2 Sanofi Introduction and Business Overview
10.12.3 Sanofi Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Sanofi Antihelminthics Products Offered
10.12.5 Sanofi Recent Development
10.13 ALLERGAN
10.13.1 ALLERGAN Company Information
10.13.2 ALLERGAN Introduction and Business Overview
10.13.3 ALLERGAN Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
10.13.4 ALLERGAN Antihelminthics Products Offered
10.13.5 ALLERGAN Recent Development
10.14 AstraZeneca
10.14.1 AstraZeneca Company Information
10.14.2 AstraZeneca Introduction and Business Overview
10.14.3 AstraZeneca Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
10.14.4 AstraZeneca Antihelminthics Products Offered
10.14.5 AstraZeneca Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antihelminthics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antihelminthics Industrial Chain Analysis
11.4 Antihelminthics Market Dynamics
11.4.1 Antihelminthics Industry Trends
11.4.2 Antihelminthics Market Drivers
11.4.3 Antihelminthics Market Challenges
11.4.4 Antihelminthics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antihelminthics Distributors
12.3 Antihelminthics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
